XBI ETF
State Street SPDR S&P Biotech ETF
XBI ETF Overview
XBI ETF (State Street SPDR S&P Biotech ETF) is managed by State Street Investment Management with $10.49B in net assets. XBI expense ratio is 0.35%, holding 313 positions across sectors including Health Care. Inception date: 2006-01-31.
XBI performance shows a YTD return of 33.87%. The 1-year return is 81.70% and the 5-year return is 4.23%. XBI dividend yield stands at 0.35%, paid quarterly.
XBI top holdings include Moderna therapeutics (3.0%), Twist Bioscience Corp. (1.8%), Natera Inc (1.5%), Halozyme Therapeutics Inc (1.5%), Kymera Therapeutics Inc (1.4%). Go to all XBI holdings, XBI sectors, or XBI dividends.
XBI can be compared against other funds. Use XBI overlap to find shared positions, or XBI vs another fund for a side-by-side view. XBI alternatives are available via the screener, along with tax-loss harvesting opportunities.